Avaí Bio Venture Reports Sustained Klotho Production in Laboratory Study

• Avaí Bio announced publication of laboratory research on sustained Klotho delivery by Klothonova, its 50/50 joint venture with Austrianova.
• Results already published in Frontiers in Aging showed encapsulated cells maintained long-term Klotho production and secretion in laboratory testing.
• The Cell-in-a-Box approach targets sustained protein delivery for age-related diseases; further studies must establish dosing, long-term safety and clinical efficacy.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Avai Bio Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610280845PRIMZONEFULLFEED9854865) on October 28, 2026, and is solely responsible for the information contained therein.